Contact Us Site Map Request More Info
 
About OKTO   Eye Care Professionals   Patients   News and Press
Home     News and Press
Full Listing
Archive


 

OKTO Welcomes Roy Chuck, M.D., Ph.D. to Surgical Advisory Board as Key Medical Consultant

COSTA MESA, California – September 20, 2002 – OKTO Ophtho, the premier developer and distributor of specialty technologies for eye surgery, announced today the addition of Roy S. Chuck, M.D. Ph.D to its Surgical Advisory Board.

Dr. Chuck has been contracted to consult and advise OKTO on a variety of medical, clinical and regulatory affairs.

Dr. Roy Chuck, a UC Berkeley trained engineer, graduated from Columbia University College of Physicians and Surgeons in 1993 with an M.D., Ph.D.

From 1997 to 1998, he served as Chief Resident and faculty member at Washington Hospital/Barnes Hospital in St. Louis. In June 1999, Dr. Chuck completed a cornea and refractive surgery fellowship at the Doheny Eye Institute/University of Southern California.

Dr. Chuck is now uniquely positioned at the University California at Irvine as both a professor of the Ophthalmology and Biomedical Engineering departments. Dr. Chuck’s focus is in cellular, molecular and laser-based biophysical studies. In addition, he has a strong clinical research interest in ocular surface transplantation and sight restoration.

“OKTO Ophtho is in the launch and developmental stages with several key surgical technologies. Dr. Chuck’s enthusiastic support of our corporate focus and philosophy, coupled with his vast experience and innovative approach, is critical to our ongoing development”, stated Erich Ziegler, OKTO’s President and CEO.

About OKTO

Founded in 2000, OKTO Ophtho develops and commercializes specialized, leading-edge surgical technologies for eye surgery. OKTO’s purpose is to develop surgical solutions that improve the quality of life for patients, elevate the performance and productivity of eye care professionals, and lower costs to the provider.

OKTO currently holds leadership positions with surgical devices for oculoplastic surgeries and bio-implant technologies for ocular surface/ophthalmic reconstructive

Media Contact:

pr@oktoophtho.com